Pacing and AV junction ablation in end-stage heart failure with atrial fibrillation
Compares an ICD alone with an ICD plus pacing and ablation in these patients.
Key facts
- Who runs it
- Yonsei University
- Where
- Seoul, South KoreaSee the site
- Trial code
- Registry title
- Conduction System Pacing and AV Junction Ablation in Heart Failure With Atrial Fibrillation (SYNC AF-HTx)
- Status
- Not yet recruiting
- People taking part
- 120 people, planned
- Started
- Jan 2026
- Expected to end
- May 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- LBBP + AVJ Ablation with ICD
- ICD Only
- Record updated
- 12 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with end-stage heart failure and long-lasting atrial fibrillation who are considered for a heart transplant or an LVAD and need an ICD.
- Age
- 19 years or older
- Sex
- All sexes
- Disease stage
- End-stage heart failure with permanent atrial fibrillation (longer than 6 months) that is not suited for catheter ablation or did not respond to it; LVEF 35 or lower within 6 weeks before enrollment; NYHA class II or higher
- Earlier treatment
- Guideline-directed medical therapy (GDMT) for at least 3 months
Main reasons for not taking part
- Already has an LVAD or had a heart transplant
- Needs cardiac resynchronization therapy (CRT)
- Has had a mechanical tricuspid valve replacement
- Expected survival of 12 months or less
- Cannot follow the study protocol
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Candidates for ICD implantation (primary or secondary prevention). Permanent AF (>6 months) unsuitable for or failed catheter ablation. End-stage heart failure considering heart transplant or LVAD. LVEF ≤ 35 within 6 weeks before enrollment. NYHA functional class ≥ II. On GDMT for at least 3 months. Age ≥ 19 years
Who cannot take part
- Existing LVAD or prior heart transplantation. Indications for cardiac resynchronization therapy (CRT). History of mechanical tricuspid valve replacement. Expected survival≤ 12 months. Inability to comply with the study protocol
Where in South Korea
- Division of Cardiology, Yonsei University College of Medicine.Seoul, South KoreaContact: tae hoon kim, MD, PhDNot yet recruiting
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the safety and efficacy of conduction system pacing (CSP) using left bundle branch pacing (LBBP) and atrioventricular junction (AVJ) ablation in patients with end-stage heart failure and permanent atrial fibrillation (AF). Participants who are candidates for heart transplantation or left ventricular assist device (LVAD) implantation will be randomized to either the SYNC group (ICD implantation combined with LBBP and AVJ ablation) or the control group (ICD implantation only). The investigators will compare clinical outcomes, including mortality and heart failure hospitalization, between the two strategies over a 1-year follow-up period.
The 2 groups in the trial
- SYNC groupTreatment being tested
Combined procedure of ICD implantation, LBBP lead insertion, and AVJ ablation.
Treatment: LBBP + AVJ Ablation with ICD
- Control groupExisting treatment, for comparison
Standard ICD implantation with minimal ventricular pacing strategy.
Treatment: ICD Only
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Safety and efficacY of conductioN System paCing and Atrioventricular Junctional Ablation Combined With ICD Implantation in Patients With End-stage Heart Failure and Atrial Fibrillation Eligible for Heart Transplantation (SYNC AF-HTx) : Multicenter Prospective Randomized Controlled Trial
- Plain-language title
- Pacing and AV junction ablation in end-stage heart failure with atrial fibrillationGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 12 January 2026